Your browser doesn't support javascript.
loading
Insights of biopolymeric blended formulations for diabetic wound healing.
Sharma, Ameya; Dheer, Divya; Puri, Vivek; Alsayari, Abdulrhman; Wahab, Shadma; Kesharwani, Prashant.
Affiliation
  • Sharma A; Chitkara University School of Pharmacy, Chitkara University, Baddi 174103, Himachal Pradesh, India.
  • Dheer D; Chitkara University School of Pharmacy, Chitkara University, Baddi 174103, Himachal Pradesh, India; Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali 140306, Punjab, India.
  • Puri V; Chitkara University School of Pharmacy, Chitkara University, Baddi 174103, Himachal Pradesh, India. Electronic address: vivek.puri@chitkarauniversity.edu.in.
  • Alsayari A; Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
  • Wahab S; Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
  • Kesharwani P; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India. Electronic address: prashantdops@gmail.com.
Int J Pharm ; 656: 124099, 2024 May 10.
Article in En | MEDLINE | ID: mdl-38614431
ABSTRACT
Diabetic wounds (DWs) pose a significant health burden worldwide, with their management presenting numerous challenges. Biopolymeric formulations have recently gained attention as promising therapeutic approaches for diabetic wound healing. These formulations, composed of biocompatible and biodegradable polymers, offer unique properties such as controlled drug release, enhanced wound closure, and reduced scarring. In this review, we aim to provide a comprehensive overview of the current state of research and future prospects regarding the application of biopolymeric formulations for diabetic wound healing. The review begins by highlighting the underlying pathophysiology of DWs, including impaired angiogenesis, chronic inflammation, and compromised extracellular matrix (ECM) formation. It further explores the key characteristics of biopolymeric materials, such as their biocompatibility, biodegradability, and tunable physicochemical properties, which make them suitable for diabetic wound healing applications. The discussion further delves into the types of biopolymeric formulations utilized in the treatment of DWs. These include hydrogels, nanoparticles (NP), scaffolds, films, and dressings. Furthermore, the review addresses the challenges associated with biopolymeric formulations for diabetic wound healing. In conclusion, biopolymeric formulations present a promising avenue for diabetic wound healing. Their unique properties and versatility allow for tailored approaches to address the specific challenges associated with DWs. However, further research and developments are required to optimize their therapeutic efficacy, stability, manufacturing processes, and regulatory considerations. With continued advancements in biopolymeric formulations, the future holds great promise for improving the management and outcomes of DWs.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Wound Healing Limits: Animals / Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Wound Healing Limits: Animals / Humans Language: En Year: 2024 Type: Article